| Name | Title | Contact Details |
|---|---|---|
James Bucher |
Chief Legal Officer | Profile |
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines. Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.
Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes.
cladribine, fluphenazine decanoate, pentamidine isethionate, fludarabine phosphate, phentolamine, chloramphenicol, api, us api manufacturer, us api supplier, best gmp manufacturer, most reliable source of api
The Heart of Healthtech Beats Here. We proudly serve as the voice of the #healthtech industry in New England, representing companies changing the world.
Provident Research is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.